BACKGROUND AND AIMS: The aim of the present study was to measure the test-retest validity of Parkinson's Disease Sleep Scale 2nd version (PDSS-2) on PD patients with stable medication and motor symptoms over the period of 4 weeks. METHODS: The subject population consisted of 92 PD patients. Besides PDSS-2, Unified PD rating scale, Montgomery-Asberg Depression Rating Scale and EQ-5D were assessed at baseline and 4 weeks later. RESULTS: The total score of PDSS-2 decreased from 19.06 ± 10.78 points to 18.00 ± 9.34 points (p > 0.05). For the total score of PDSS-2 the Intra-class and Lin's Concordance Correlation Coefficients were 0.782 and 0.799. The average difference between the baseline and follow-up total PDSS-2 scores was -1.06 points with the 95% confidence interval of -7.96 and +5.84 points. CONCLUSIONS: Our data supports that the items and the total score of PDSS-2 have acceptable test-retest reliability over a four week period on patients with stable PD symptoms and pharmacological therapy.
BACKGROUND AND AIMS: The aim of the present study was to measure the test-retest validity of Parkinson's DiseaseSleep Scale 2nd version (PDSS-2) on PDpatients with stable medication and motor symptoms over the period of 4 weeks. METHODS: The subject population consisted of 92 PDpatients. Besides PDSS-2, Unified PD rating scale, Montgomery-Asberg Depression Rating Scale and EQ-5D were assessed at baseline and 4 weeks later. RESULTS: The total score of PDSS-2 decreased from 19.06 ± 10.78 points to 18.00 ± 9.34 points (p > 0.05). For the total score of PDSS-2 the Intra-class and Lin's Concordance Correlation Coefficients were 0.782 and 0.799. The average difference between the baseline and follow-up total PDSS-2 scores was -1.06 points with the 95% confidence interval of -7.96 and +5.84 points. CONCLUSIONS: Our data supports that the items and the total score of PDSS-2 have acceptable test-retest reliability over a four week period on patients with stable PD symptoms and pharmacological therapy.
Authors: Fanni Rencz; László Gulácsi; Michael Drummond; Dominik Golicki; Valentina Prevolnik Rupel; Judit Simon; Elly A Stolk; Valentin Brodszky; Petra Baji; Jakub Závada; Guenka Petrova; Alexandru Rotar; Márta Péntek Journal: Qual Life Res Date: 2016-07-29 Impact factor: 4.147
Authors: Sanghee Moon; Caio V M Sarmento; Michael Steinbacher; Irina V Smirnova; Yvonne Colgrove; Sue-Min Lai; Kelly E Lyons; Wen Liu Journal: Complement Ther Clin Pract Date: 2020-04-02 Impact factor: 2.446
Authors: Pablo Martinez-Martin; John B Wetmore; Carmen Rodríguez-Blázquez; Tomoko Arakaki; Oscar Bernal; Victor Campos-Arillo; Christopher Cerda; Ingrid Estrada-Bellmann; Nélida Garretto; Letty Ginsburg; Jorge Uriel Máñez-Miró; Juan Carlos Martínez-Castrillo; Ivonne Pedroso; Marcos Serrano-Dueñas; Carlos Singer; Mayela Rodríguez-Violante; Francisco Vivancos Journal: Mov Disord Clin Pract Date: 2019-03-18
Authors: Krisztina Horváth; Zsuzsanna Aschermann; Péter Ács; Gabriella Deli; József Janszky; Sámuel Komoly; Kázmér Karádi; Márton Kovács; Attila Makkos; Béla Faludi; Norbert Kovács Journal: Parkinsons Dis Date: 2015-10-11